NEW YORK, Oct. 9 (GenomeWeb News) - Massachusetts General Hospital and CytRx try to use RNAi technology to develop a drug to prevent and cure amyotrophic lateral sclerosis, the groups said today.
   
The agreement comes on the heels of an RNAi-based research program CytRx penned with the University of Massachusetts Medical School - from which the company recently acquired an exclusive licenses to the RNAi technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.